2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$66.72+$1.02 (+1.54%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.2BMarket Cap
- 588.68%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$66.72+$1.02 (+1.54%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 98.4M +9.22% | 90.1M -2.10% | 92.1M -9.67% | |
Cost of Revenue | 0 -100.00% | 30.7M -9.13% | 33.8M +56.08% | 21.6M -13.10% | |
Gross Profit | 0 -100.00% | 67.7M +20.21% | 56.4M -19.97% | 70.4M -8.56% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -2.6M -97.82% | -120.9M +5.91% | -114.2M -47.71% | -218.3M -45.46% | |
Depreciation and Amortization Expense | 1.0M -76.63% | 4.4M -43.81% | 7.8M -40.02% | 13.0M -7.89% | |
Total Operating Expenses | 195.3M -4.07% | 203.6M -42.45% | 353.8M -24.44% | 468.2M -14.56% | |
Operating Profit | -140.1M +33.18% | -105.2M -60.10% | -263.7M -29.90% | -376.2M -15.68% | |
Interest Income | 10.4M -28.01% | 14.5M -23.72% | 19.0M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Interest Income and Expense and Net | 10.4M -28.01% | 14.5M -23.72% | 19.0M N/A | 0 N/A | |
Total Nonoperating Income and Expense | -15.4M +9.88% | -14.0M +11.37% | -12.6M -212.42% | 11.2M +114.49% | |
Income before Taxes | -155.5M +30.44% | -119.2M -56.85% | -276.3M -24.31% | -365.0M -30.25% | |
Income Taxes | -138,000 -42.26% | -239,000 +19.50% | -200,000 -106.22% | 3.2M +477.20% | |
Extraordinary Items | 3.8M -47.95% | 7.3M -88.90% | 65.8M 0.00% | 65.8M N/A | |
Net Income | -164.1M +37.92% | -119.0M -56.91% | -276.1M -25.03% | -368.2M -29.71% | |
Net Income from Continuing Operations Applicable to Common | -164.1M +37.65% | -119.2M -56.85% | -276.3M -24.31% | -365.0M -30.25% | |
Basic EPS and Net Income | -9.73 +1,577.59% | -0.58 -60.00% | -1.45 -26.40% | -1.97 -31.12% | |
Diluted EPS and Net Income | -9.73 +1,577.59% | -0.58 -60.00% | -1.45 -26.40% | -1.97 -31.12% | |
Basic Weighted Average Shares | 16.9M -91.80% | 205.7M +8.24% | 190.0M +1.53% | 187.1M +2.09% | |
Diluted Weighted Average Shares | 16.9M -91.80% | 205.7M +8.24% | 190.0M +1.53% | 187.1M +2.09% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 15.1M -65.84% | 44.3M +25.44% | 35.3M -60.02% | 88.2M +249.86% | |
Short-Term Investments | 230.6M +9.32% | 211.0M -21.38% | 268.3M -35.61% | 416.8M -41.20% | |
Cash and Cash Equivalents and Short-Term Investments | 245.8M -3.71% | 255.2M -15.94% | 303.6M -39.88% | 505.0M -31.20% | |
Total Current Assets | 266.3M +1.90% | 261.3M -20.99% | 330.7M -39.43% | 546.0M -31.37% | |
Accumulated Depreciation | N/A N/A | 15.9M -81.69% | 86.9M -30.33% | 124.7M -15.74% | |
Property and Plant and Equipment and Net | 2.1M -39.61% | 3.4M -81.91% | 18.9M -41.89% | 32.5M -46.37% | |
Total Long-Term Assets | 5.6M +21.54% | 4.6M +0.06% | 4.6M +106.86% | 2.2M -18.19% | |
Total Assets | 280.4M -7.72% | 303.9M -23.66% | 398.0M -43.99% | 710.6M -36.39% | |
Income Taxes Payable | 1.1M +450.00% | 200,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 53.5M -12.81% | 61.4M +19.76% | 51.3M -24.83% | 68.2M -19.95% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 8.6M +19.11% | 7.2M +56.22% | 4.6M -38.62% | 7.6M +110.22% | |
Total Liabilities | 190.6M -21.61% | 243.1M -8.96% | 267.0M -22.36% | 344.0M -21.41% | |
Retained Earnings | -3.8B +4.56% | -3.6B +3.42% | -3.5B +8.62% | -3.2B +13.00% | |
Total Stockholders Equity | 89.8M +47.90% | 60.7M -53.63% | 131.0M -64.27% | 366.6M -46.04% | |
Total Shares Outstanding | 20.4M -89.03% | 185.8M -2.93% | 191.4M +1.50% | 188.6M +1.67% | |
Cash Flow | |||||
Cash from Operating Activities | -208.5M +18.67% | -175.7M -8.77% | -192.6M -36.64% | -304.0M -26.33% | |
Capital Expenditures | 171,000 -88.35% | 1.5M +69.71% | 865,000 -84.76% | 5.7M -62.13% | |
Cash from Investing Activities | -1.2M -100.84% | 142.6M +2.15% | 139.6M -61.85% | 365.8M +80.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 180.6M +328.71% | 42.1M +140,293.33% | 30,000 -98.01% | 1.5M -95.84% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 68.82% +10.06% | 62.53% -18.26% | 76.50% +1.23% | |
Operating Margin | N/A N/A | -106.88% -63.47% | -292.59% -28.40% | -408.63% -6.65% | |
Return on Assets | -56.17% +65.69% | -33.90% -31.93% | -49.80% +23.61% | -40.29% +2.14% | |
Return on Equity | -217.94% +75.62% | -124.10% +11.85% | -110.95% +57.62% | -70.39% +18.04% | |
Revenue Growth | -100.00% -1,185.15% | 9.22% +538.87% | -2.10% -78.28% | -9.67% -71.02% | |
Current Ratio | 4.97 +16.87% | 4.26 -34.02% | 6.45 -19.42% | 8.00 -14.27% | |
Cash Ratio | 0.28 -60.82% | 0.72 +4.74% | 0.69 -46.81% | 1.29 +337.03% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow